133 results on '"P.G. Arcidiacono"'
Search Results
2. RNA-SEQUENCING OF PANCREATIC CANCER FROM EUS-ACQUIRED TISSUE IS USEFUL TO DEFINE MOLECULAR SUBTYPES AND PROGNOSIS
3. REPEATED EUS-GUIDED FINE NEEDLE BIOPSY AFTER NON-DIAGNOSTIC OR INCONCLUSIVE RESULTS OF SOLID PANCREATIC MASSES – THE REUBIO STUDY
4. Association of genetic variants affecting microRNAs and pancreatic cancer risk
5. V.01.1 EUS-DIRECTED TRANS-ENTERIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY WITH GIANT INTRAHEPATIC STONE LITHOTRIPSY AFTER A LAMS-IN-LAMS RESCUE OF A MISDEPLOYMENT
6. V.01.5 EUS-DIRECTED TRANS-GASTRIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (EDGE) IN TWICE SURGICALLYALTERED ANATOMY: ROUX-EN-Y GASTRIC BYPASS AFTER SLEEVE GASTRECTOMY
7. T.04.1 EUS-GUIDED GASTROENTEROSTOMY VERSUS ENTERAL STENTING FOR FRAILER PATIENTS WITH MALIGNANT GASTRIC OUTLET OBSTRUCTION: A MATCHED PROSPECTIVE COMPARISON
8. OC.13.2 ENDOSCOPIC PAPILLECTOMY: A MULTICENTER, RETROSPECTIVE, NATIONWIDE STUDY AFTER THE STANDARDISATION OF THE TECHNIQUE
9. T.03.9 SPLICING REGULATION AS A NEW POTENTIAL PROGNOSTIC TOOL FOR PERSONALIZED MEDICINE IN PDAC
10. PC.01.10 EFFICACY AND SAFETY OF PLASTIC, COVERED AND UNCOVERED SELF-EXPANDABLE METAL STENTS IN THE TREATMENT OF MALIGNANT BILIARY OBSTRUCTIONS
11. OC.01.1 EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY
12. T.11.9 DIAGNOSTIC DELAY IN PANCREATIC CANCER CORRELATES WITH STAGE AT DIAGNOSIS
13. Changes of oral and duodenal microbiota in patients with pancreatic cancer are possible diagnostic and prognostic biomarkers
14. V.01.5 CLIPPING OF DUODENAL DIVERTICULUM AS TREATMENT FOR RECURRENT CHOLANGITIS DUE TO BILIARY COMPRESSION (LEMMEL’S SYNDROME)
15. OC.09.5 REPEATED EUS-GUIDED FINE NEEDLE BIOPSY OF PANCREATIC MASSES AFTER NON-DIAGNOSTIC OR INCONCLUSIVE RESULTS – THE REUBIO STUDY
16. V.01.8 REDO-EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF DISTAL FLANGE MISDEPLOYMENT: TRUST YOUR ORO-JEJUNAL CATHETER
17. V.01.3 OVER-THE-WIRE LUMEN APPOSING METAL STENT EXCHANGE FOR MANAGEMENT OF A LONG-TERM CHOLEDOCHODUODENOSTOMY DYSFUNCTION
18. T.05.3 LIMITED CLINICAL USEFULNESS OF PREDICTIVE SCORES FOR ASSESSMENT OF ACUTE PANCREATITIS SEVERITY: A SYSTEMATIC REVIEW AND META-ANALYSIS WITH PRE AND POST-TEST PROBABILITY ASSESSMENT
19. OC.01.2 CHANGES OF ORAL AND DUODENAL MICROBIOTA IN PATIENTS WITH PANCREATIC CANCER ARE POSSIBLE DIAGNOSTIC AND PROGNOSTIC BIOMARKERS
20. OC.09.3 RELIABILTY OF PREOPERATIVE PANCREATIC NEUROENDOCRINE TUMORS GRADING ON ENDOSCOPIC ULTRASOUND SPECIMENS: A SYSTEMATIC REVIEW WITH META-ANALYSIS
21. OC.09.4 LONG-TERM PATENCY AND NEED-FOR-REINTERVENTIONS OF EUS-GUIDED CHOLEDOCODUODENOSTOMY WITH ELECTROCAUTERY-ENHANCED LUMEN APPOSING METAL STENTS: A SINGLE-CENTRE PROSPECTIVE EVALUATION
22. OC.14.3 RADIATION EXPOSURE DURING MODERN THERAPEUTIC EUS PROCEDURES: IMPLICATIONS FOR PATIENTS AND HEALTH-CARE WORKERS
23. OC.14.5 OUTCOMES OF COMBINED MANAGEMENT BILIARY AND GASTRIC OUTLET OBSTRUCTION (CABRIOLET STUDY): A MULTICENTRE RETROSPECTIVE ANALYSIS
24. AF.104 RNA-SEQUENCING OF PANCREATIC CANCER FROM EUSACQUIRED TISSUE IS USEFUL TO DEFINE MOLECULAR SUBTYPES AND PROGNOSIS
25. OC.10.9 GLUCOSE AND LACTATE LEVELS ARE LOWER IN EUS-ASPIRATED CYST FLUID OF MUCINOUS VS NON-MUCINOUS PANCREATIC CYSTIC LESIONS
26. AF.100 RITUXIMAB FOR INDUCTION OF REMISSION IN IGG4-RELATED PANCREATO-BILIARY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
27. AF.103 CHANGES OF THE DUODENAL MICROBIOTA IN PATIENTS WITH PANCREATIC CANCER ARE NOT RELATED WITH BILE AND PANCREATIC DUCT OBSTRUCTION
28. OC.10.3 LUMEN-APPOSING METAL STENTS FOR EUS-GUIDED DRAINAGE OF WALLED-OFF PANCREATIC NECROSIS: RESULTS OF A LARGE MULTICENTER COHORT
29. EUS-ablation with hybridtherm probe plus chemotherapy versus chemotherapy alone in locally advanced/borderline resectable pancreatic cancer: A phase II randomized controlled trial
30. Morphologic endoscopic ultrasound features in the differential diagnosis between type 1 focal autoimmune pancreatitis and pancreatic cancer
31. Laparoscopic versus EUS-guided gastroenterostomy for gastric outlet obstruction: An international multicenter propensity score-matched comparison
32. Immunomodulation induced by EUS-ablation with hybridtherm-probe in locally advanced and borderline resectable pancreatic cancer: results from a phase II randomized controlled trial
33. ENDOSCOPIC ULTRASOUND (EUS)-GUIDED RADIOFREQUENCY ABLATION (RFA) OF A SYMPTOMATIC PANCREATIC INSULINOMA
34. INTEROBSERVER AGREEMENT OF ENDOSCOPIC ULTRASOUND ASSESSMENT AND MANAGEMENT OF PANCREATIC FLUID COLLECTIONS (PFCS) - AN INTERNATIONAL STUDY
35. ENDOSCOPIC ULTRASOUND-FINE NEEDLE ASPIRATION (EUS-FNA) DIAGNOSTIC ACCURACY IN THE EVALUATION OF PANCREATIC NEUROENDOCRINE NEOPLASMS (PNEN) GRADING
36. FEASIBILITY AND OPTIMIZATION OF RNA EXTRACTION FROM EUS-ACQUIRED TISSUE IN PANCREATIC CANCER
37. STARK STUDY: MACHINE LEARNING APPROACH TO PREDICT POST-ERCP PANCREATITIS IN AN INTERNATIONAL MULTICENTER PROSPECTIVE COHORT STUDY
38. DIAGNOSTIC ACCURACY OF INTRACYSTIC GLUCOSE AS COMPARED WITH CEA FOR THE DIAGNOSIS OF MUCINOUS PANCREATIC CYSTIC LESIONS: A META ANALYSIS
39. GLUCOSE LEVELS IN EUS-ASPIRATED CYST FLUID HAVE A HIGH ACCURACY FOR THE DIAGNOSIS OF MUCINOUS PANCREATIC CYSTIC LESIONS
40. A Pancreatic Cystic Neoplasms Drama. Accuracy of Diagnostic Presumption and Surgical Indication on a Ten-year Experience
41. OC.03.7 ENDOSCOPIC ULTRASOUND-GUIDED ABLATION WITH HYBRIDTHERM PROBE IN ADDITION TO CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR THE TREATMENT OF LOCALLY ADVANCED OR BORDERLINE RESECTABLE PANCREATIC CANCER: A PHASE II RANDOMIZED CONTROLLED TRIAL
42. AF.1 IDENTIFICATION OF RISK FACTORS FOR THE OCCURRENCE OF AMPULLARY TUMORS: A CASE-CONTROL STUDY
43. AF.149 SIGNATURE ENDOSCOPIC ULTRASOUND FEATURES ARE HELPFUL IN THE DIFFERENTIAL DIAGNOSIS BETWEEN TYPE 1 FOCAL AUTOIMMUNE PANCREATITIS AND PANCREATIC CANCER: A PROOF-OF-CONCEPT STUDY
44. PC.01.4 LUMEN-APPOSING METAL STENT FOR EUS-GUIDED DRAINAGE OF PANCREATIC PSEUDOCYSTS: RESULTS FROM A LARGE MULTICENTER COHORT
45. PC.01.1 LAPAROSCOPIC VERSUS EUS-GUIDED GASTROENTEROSTOMY FOR GASTRIC OUTLET OBSTRUCTION: AN INTERNATIONAL MULTICENTER PROPENSITY SCORE-MATCHED COMPARISON
46. Management of IPMNs with worrisome features: A clinical dilemma
47. Rituximab for induction of remission in type 1 autoimmune pancreatitis: A systematic review and meta-analysis
48. RNA-sequencing of pancreatic cancer from EUS-acquired tissue is useful to define molecular subtypes and prognosis
49. Intracystic glucose is more accurate than carcinoembryonic antigen for the diagnosis of mucinous pancreatic cystic lesions: A meta-analysis
50. What is the rate of correct surgical indication in patients with BD-IPMNs?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.